In particular, ROS-induced mutations on p53 can lead to dysregulation of neoangiogenesis and the progression from low- to high-grade gliomas via transcriptional activation of VEGF and FGF expression [156,157,158]. This evidence concerns the gene VEGFA and central nervous system cancer.